StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health AFS Fixed Maturity Securities by Quarter

AFS Fixed Maturity Securities — Gross Unrealized Losses ($M)

QuarterlyAnnual

Elevance Health AFS Fixed Maturity Securities: $1,555M in Q3 2026, up 186.9% from a year earlier.

Latest, Q3 2026
1,555
Period ended Sep 30, 2026
Change on a year earlier
+186.9%
542 in Q3 2025
History
31 quarters
Since Q1 2015
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax (2026-09-30): 1,555,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Fixed Maturity Securities — Gross Unrealized Losses ($M)Year on yearSource
Q3 2026Sep 30, 20261,555+186.9%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q2 2026Jun 30, 2026580-13.0%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2026Mar 31, 2026611-18.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2025Dec 31, 2025494-49.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q3 2025Sep 30, 2025542-19.6%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q2 2025Jun 30, 2025667-47.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2025Mar 31, 2025746-42.6%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2024Dec 31, 2024970-27.5%ELV 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q3 2024Sep 30, 2024674-72.3%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q2 2024Jun 30, 20241,261-37.7%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2024Mar 31, 20241,299-32.4%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2023Dec 31, 20231,338-43.7%ELV 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q3 2023Sep 30, 20232,435-15.4%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q2 2023Jun 30, 20232,025–ELV 10-Q/A (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2023Mar 31, 20231,922–ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2022Dec 31, 20222,378+1,206.6%ELV 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗

Cite this data

StockData. (2026). Elevance Health AFS Fixed Maturity Securities ($M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-afs-debt-unrealized-loss

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.